Sort by
Refine Your Search
-
information on benefits and eligibility, please visit: http://uhr.rutgers.edu/benefits/benefits-overview . Posting Summary The fellow will work with Dr. Greta Bushnell, Assistant Professor of Epidemiology
-
interdisciplinary team working on the development of digital twin models for critically ill patients in the intensive care unit (ICU). This position offers a unique opportunity to contribute to a cutting-edge project
-
in the implementation of the programs and projects in special areas of interest to the laboratory. Contributes to the development of performance standards, selection of methodology and instrumentation
-
of the Postdoctoral Associate position is to conduct independent laboratory research under the direction of the Principal Investigator. The research interest of the Feng lab is to study the development and progression
-
and maintains experimental equipment. Records and analyzes data from experiments. Contributes to the development of performance standards, selection of methodology, instrumentation and coordination
-
developing the PI’s grant applications, and will be expected to apply for personal grant funding. As part of their career development to transition to the next phase of their career, the applicant(s) will be
-
Investigator, the Postdoctoral Associate(s) will be responsible for the performance and analysis of experiments focused on development and function of novel immune cells. Our research focuses on development and
-
opportunities for professional development, including mentored training in experimental study design and data analysis, manuscript preparation, and grant writing. The Postdoctoral Associate will also assist in
-
developing the PI’s grant applications, and will be expected to apply for personal grant funding. As part of their career development to transition to the next phase of their career, the applicant(s) will be
-
in the Principal Investigator’s laboratory to conduct research on tumor immunology, with a focus on the discovery and development of T cell therapy for cancer, including tumor-infiltrating lymphocytes